Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Convergent of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Longstanding Persistent AF

NCT05393180 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT05393180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05393180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Convergent of Epicardial and Endocardial RF Ablation for the Treatment of Symptomatic Longstanding Persistent AF
Lead sponsor
AtriCure, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 13, 2022
Completion date
November 21, 2028
Enrollment
53 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic atrial fibrillation